Chris Vervaet
Impact in
- Pharmaceutical Science top 0.01%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Analytical Chemistry top 0.05%
- Spectroscopy and Chemometric Analyses
Papers in
-
- Drug Solubulity and Delivery Systems 193
- Advanced Drug Delivery Systems 58
-
- Spectroscopy and Chemometric Analyses 34
- Co-authors
- Jean Paul RemonThomas De BeerValérie VanhoorneMargot FonteyneJurgen VercruysseA. BurggraeveJ.P. RemonLien Saerens
- Journals
- International Journal of Pharmaceutics (120 papers)European Journal of Pharmaceutics and Biopharmaceutics (72 papers)European Journal of Pharmaceutical Sciences (22 papers)Pharmaceutics (15 papers)Pharmaceutical Research (9 papers)
- Partner nations
- BelgiumNetherlandsGermany
In The Last Decade
Chris Vervaet
395 papers receiving 14.1k citations
Hit Papers
Peers
Comparison fields: 5 of 189
- Pharmaceutical Science 5.7k
- Analytical Chemistry 2.2k
- Biophysics 912
- Biomaterials 1.7k
- Computational Mechanics 2.2k
Countries citing papers authored by Chris Vervaet
This map shows the geographic impact of Chris Vervaet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Vervaet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Vervaet more than expected).
Fields of papers citing papers by Chris Vervaet
This network shows the impact of papers produced by Chris Vervaet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Vervaet. The network helps show where Chris Vervaet may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Vervaet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 13 | |
| 11 | 2023 | 10 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 15 | |
| 14 | 2021 | 20 | |
| 15 | 2018 | 87 | |
| 16 | Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts | 2018 | 1 |
| 17 | 2018 | 47 | |
| 18 | 2017 | 6 | |
| 19 | 2016 | 137 | |
| 20 | 2015 | 19 |
About Chris Vervaet
Chris Vervaet is a scholar working on Pharmaceutical Science, Analytical Chemistry, Food Science, Biomaterials and Biophysics, having authored 400 papers that have together received 14.5k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (193 papers), Protein purification and stability (69 papers), Advanced Drug Delivery Systems (58 papers), Granular flow and fluidized beds (57 papers), Microencapsulation and Drying Processes (41 papers), Crystallization and Solubility Studies (34 papers), Spectroscopy and Chemometric Analyses (34 papers) and Mineral Processing and Grinding (33 papers). The work is most often cited by research in Pharmaceutical Science (5.7k citations), Analytical Chemistry (2.2k citations), Biophysics (912 citations), Biomaterials (1.7k citations) and Computational Mechanics (2.2k citations). Chris Vervaet has collaborated with scholars based in Belgium, Netherlands and Germany. Frequent co-authors include Jean Paul Remon, Thomas De Beer, Valérie Vanhoorne, Margot Fonteyne, Jurgen Vercruysse, A. Burggraeve, J.P. Remon, Lien Saerens, Bruno G. De Geest and J.P. Remon. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, European Journal of Pharmaceutical Sciences, Pharmaceutics and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.